Oregon cannabis prices fall to record low but consumer demand steady

 Oregon cannabis sales declined slightly in 2025 despite record-breaking cultivation production that saw retail prices fall to historic lows.

Annual sales fell from $960 million in 2024 to $925.5 million in 2025, according to Oregon Liquor & Cannabis Commission data, continuing a downward trend from the COVID-19 pandemic-driven peak of $1.2 billion in 2021. 

Read the whole story HERE.

Mississippi Lawmakers Approve Bill To Allow Medical Marijuana Use In Hospitals For Terminally Ill Patients

 Mississippi lawmakers have approved a bill to allow terminally ill patients to access medical marijuana in hospitals, nursing facilities and hospice centers.

As state legislatures across the country consider a variety of similar proposals, the Mississippi House Public Health and Human Services Committee on Wednesday took a step to advance the reform, recommending the passage of HB 1034 from Rep. Kevin Felsher (R).

Read the full story HERE

Congress’ Retreat on Blocking Trump’s Rescheduling Order Leads CBT’s Top Stories in January

 President Donald Trump issued his executive order on cannabis rescheduling in December, but Cannabis Business Times’ readers in January were most interested in knowing whether Congress would block his administration from following through.
After language aimed at stripping the Department of Justice’s power to reschedule marijuana was included in an earlier version of a government funding package in September, the U.S. House and Senate Appropriations committees released a bicameral package on Jan. 5 that removed the proposal from the final version of the fiscal year 2026 Commerce, Justice, Science (CJS) and Related Agencies appropriations bill. 

Read the whole story HERE

Democratic Lawmakers File Bill To Federally Legalize Marijuana As Trump Weighs Rescheduling

As the Trump administration considers rescheduling marijuana, Congressional Democrats have filed a bill to federally legalize cannabis by descheduling it altogether. In addition to removing the drug from the Controlled Substances Act (CSA), the new legislation also contains a variety of provisions meant to promote equity and address the collateral consequences of prohibition. Read the whole story HERE

Researchers Announce They’ve Discovered A New Cannabinoid In Marijuana via Marajuana Moment

Researchers have announced that they’ve successfully identified a new cannabinoid—cannabielsoxa—produced by the marijuana plant as well as a number of other compounds “reported for the first time from the flowers of C. sativa.” The team of government and university researchers out of South Korea also evaluated 11 compounds in cannabis for antitumor effects in neuroblastoma cells, finding that seven “revealed strong inhibitory activity.” Read the full story HERE

Oregon Officials Don’t Know If $46M Used To Fight The Unlicensed Marijuana Market Has Accomplished Anything

by Marajuana Moment

The tales of illicit cannabis operations were coming from all corners of Oregon, and by 2018—four years after the state voted to legalize recreational weed—lawmakers were feeling the pressure to act.Workers on unlicensed grows just miles north of California were sleeping in shipping containers and being held on site by armed guards. In clandestine hash oil laboratories in Central Oregon and Portland, jerry-rigged electrical wiring and pressurized butane gas had sparked explosions, blasting buildings apart and sometimes scorching people to death. Along the coast, local sheriff’s deputies were intercepting hundreds of pounds of processed marijuana bound for Texas and Florida, bypassing state inspectors and tax collectors on the way out. Read the whole story HERE

What marijuana reclassification means for the United States

The U.S. Drug Enforcement Administration is moving toward reclassifying marijuana as a less dangerous drug. The Justice Department proposal would recognize the medical uses of cannabis, but wouldn’t legalize it for recreational use. The proposal would move marijuana from the “Schedule I” group to the less tightly regulated “Schedule III.” So what does that mean, and what are the implications? Read the full story HERE